Privia Health Group (PRVA) Insider Trading & Ownership $21.79 +0.04 (+0.19%) As of 02:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Privia Health Group (NASDAQ:PRVA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$3.73M Get PRVA Insider Trade Alerts Want to know when executives and insiders are buying or selling Privia Health Group stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRVA Insider Buying and Selling by Quarter Privia Health Group Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/12/2025David MountcastleCFOSell3,322$24.99$83,016.78 5/12/2025Parth MehrotraCEOSell13,773$24.99$344,187.27 4/30/2025David MountcastleCFOSell3,445$23.33$80,371.85 4/30/2025Matthew Shawn MorrisDirectorSell10,309$23.33$240,508.97 4/30/2025Parth MehrotraCEOSell15,100$23.33$352,283.00 4/2/2025David MountcastleCFOSell5,630$22.38$125,999.40 9/10/2024Parth MehrotraCEOSell135,142$18.50$2,500,127.00 (Data available from 1/1/2013 forward) PRVA Insider Trading Activity - Frequently Asked Questions Who is on Privia Health Group's Insider Roster? The list of insiders at Privia Health Group includes Adam Boehler, Advisors L.L.C. Mbd, David Mountcastle, Jeffrey B Butler, Matthew Shawn Morris, Parth Mehrotra, Thomas A Mccarthy, Thomas Bartrum, and William M Sullivan. Learn more on insiders at PRVA. What percentage of Privia Health Group stock is owned by insiders? 10.70% of Privia Health Group stock is owned by insiders. Learn more on PRVA's insider holdings. Which Privia Health Group insiders have been buying company stock? The following insiders have purchased PRVA shares in the last 24 months: Adam Boehler ($4,581,781.05), and Thomas A Mccarthy ($163,700.00). How much insider buying is happening at Privia Health Group? Insiders have purchased a total of 293,235 PRVA shares in the last 24 months for a total of $4,745,481.05 bought. Which Privia Health Group insiders have been selling company stock? The following insiders have sold PRVA shares in the last 24 months: David Mountcastle ($441,920.00), Matthew Shawn Morris ($444,215.75), Parth Mehrotra ($3,669,648.97), Thomas Bartrum ($454,959.12), and William M Sullivan ($1,451,509.50). How much insider selling is happening at Privia Health Group? Insiders have sold a total of 309,368 Privia Health Group shares in the last 24 months for a total of $6,462,253.34 sold. Privia Health Group Key ExecutivesMr. Parth Mehrotra (Age 45)CEO & Director Compensation: $1.19M2 recent tradesMr. David Mountcastle CPA (Age 54)MBA, Executive VP, CFO & Principal Accounting Officer Compensation: $713.72k3 recent tradesMr. Thomas Bartrum (Age 56)Executive Officer Compensation: $533.02kMr. Sarath DegalaChief Operating OfficerMr. Chris VoigtExecutive VP & Chief Technology OfficerMr. Robert P. BorchertSenior Vice President of Investor Relations & Corporate CommunicationsMs. Dana Fields CPAChief Audit & Compliance OfficerMr. Edward Christopher Fargis Esq.Executive VP, General Counsel, Chief Legal Officer & Corporate SecretaryMs. Jenny HardingChief People OfficerMr. Jay StevensSenior VP & Chief Growth Officer More Insider Trading Tools from MarketBeat Related Companies Hims & Hers Health Insider Ownership Guardant Health Insider Ownership RadNet Insider Ownership Sotera Health Insider Ownership Option Care Health Insider Ownership BrightSpring Health Services Insider Ownership GeneDx Insider Ownership Surgery Partners Insider Ownership Veracyte Insider Ownership Celcuity Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NASDAQ:PRVA) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Privia Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access